Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

RPT-UPDATE 1-U.S., 13 countries concerned WHO COVID-19 origin study was delayed, lacked access -statement

Published 31/03/2021, 05:34 pm
Updated 31/03/2021, 05:36 pm

(Repeats to additional clients story first published on Tuesday, text unchanged)

WASHINGTON, March 30 (Reuters) - The United States and 13 other countries expressed concerns on Tuesday that the World Health Organization (WHO) report on the origins of the novel coronavirus that causes COVID-19 was delayed and lacked access to complete data, according to a joint statement.

It followed WHO Director-General Tedros Adhanom Ghebreyesus's assertion that data was withheld from its investigators who traveled to China to research the origins of the pandemic. is equally essential that we voice our shared concerns that the international expert study on the source of the SARS-CoV-2 virus was significantly delayed and lacked access to complete, original data and samples," the joint statement said.

The statement was signed by the governments of Australia, Canada, Czech Republic, Denmark, Estonia, Israel, Japan, Latvia, Lithuania, Norway, the Republic of Korea, Slovenia, the United Kingdom, and the United States.

China refused to provide raw data on early COVID-19 cases to the WHO-led team, one of the team's investigators has already said, potentially complicating efforts to understand how the global pandemic began.

The countries' joint statement supported further studies of animals to find how the virus was introduced to humans, and called for a renewed commitment from WHO and member countries to access, transparency and timeliness.

"It is critical for independent experts to have full access to all pertinent human, animal, and environmental data, research, and personnel involved in the early stages of the outbreak relevant to determining how this pandemic emerged," the statement said.

Establishing such guidelines for investigations will help countries detect, prepare and respond to future outbreaks, it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.